174 related articles for article (PubMed ID: 33450539)
1. Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?
Bahr TM; Ward DM; Jia X; Ohls RK; German KR; Christensen RD
Blood Cells Mol Dis; 2021 May; 88():102536. PubMed ID: 33450539
[TBL] [Abstract][Full Text] [Related]
2. Umbilical Cord Erythroferrone Is Inversely Associated with Hepcidin, but Does Not Capture the Most Variability in Iron Status of Neonates Born to Teens Carrying Singletons and Women Carrying Multiples.
Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO
J Nutr; 2021 Sep; 151(9):2590-2600. PubMed ID: 34236433
[TBL] [Abstract][Full Text] [Related]
3. Marathon Run-induced Changes in the Erythropoietin-Erythroferrone-Hepcidin Axis are Iron Dependent.
Tomczyk M; Kortas J; Flis D; Kaczorowska-Hac B; Grzybkowska A; Borkowska A; Lewicka E; Dabrowska-Kugacka A; Antosiewicz J
Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32316587
[TBL] [Abstract][Full Text] [Related]
4. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
Pirotte M; Fillet M; Seidel L; Jaspers A; Baron F; Beguin Y
Am J Hematol; 2021 Oct; 96(10):1275-1286. PubMed ID: 34310730
[TBL] [Abstract][Full Text] [Related]
5. Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia.
Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO
J Nutr; 2021 Jul; 151(7):1824-1833. PubMed ID: 33982118
[TBL] [Abstract][Full Text] [Related]
6. The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study.
Zaman BA; Rasool SO; Abdo JM
Br J Haematol; 2023 May; 201(3):547-551. PubMed ID: 36535905
[TBL] [Abstract][Full Text] [Related]
7. Cord Blood Erythropoietin and Hepcidin Reflect Lower Newborn Iron Stores due to Maternal Obesity during Pregnancy.
Korlesky C; Kling PJ; Pham DQD; Ovasapyan AA; Leyns CEG; Weber MB; Coe CL
Am J Perinatol; 2019 Apr; 36(5):511-516. PubMed ID: 30193381
[TBL] [Abstract][Full Text] [Related]
8. Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone.
Ciniselli CM; De Bortoli M; Taverna E; Varinelli L; Pizzamiglio S; Veneroni S; Bonini C; Orlandi R; Verderio P; Bongarzone I
Expert Rev Proteomics; 2015; 12(6):695-701. PubMed ID: 26496240
[TBL] [Abstract][Full Text] [Related]
9. Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial.
Breenfeldt Andersen A; Bonne TC; Bejder J; Jung G; Ganz T; Nemeth E; Olsen NV; Huertas JR; Nordsborg NB
Am J Physiol Regul Integr Comp Physiol; 2021 Aug; 321(2):R152-R161. PubMed ID: 34160288
[TBL] [Abstract][Full Text] [Related]
10. Placental Erythroferrone and Erythropoietin mRNA Expression is not Associated with Maternal or Neonatal Iron Status in Adolescents Carrying Singletons and Adult Women Carrying Multiples.
Delaney KM; Barad A; Castillo LF; Hasund CM; Guillet R; Pressman EK; Katzman PJ; Ganz T; Nemeth E; O'Brien KO
J Nutr; 2023 Jul; 153(7):1950-1958. PubMed ID: 37253412
[TBL] [Abstract][Full Text] [Related]
11. Immunoassay for human serum erythroferrone.
Ganz T; Jung G; Naeim A; Ginzburg Y; Pakbaz Z; Walter PB; Kautz L; Nemeth E
Blood; 2017 Sep; 130(10):1243-1246. PubMed ID: 28739636
[TBL] [Abstract][Full Text] [Related]
12. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
Honda H; Kobayashi Y; Onuma S; Shibagaki K; Yuza T; Hirao K; Yamamoto T; Tomosugi N; Shibata T
PLoS One; 2016; 11(3):e0151601. PubMed ID: 26978524
[TBL] [Abstract][Full Text] [Related]
13. Erythroferrone structure, function, and physiology: Iron homeostasis and beyond.
Srole DN; Ganz T
J Cell Physiol; 2021 Jul; 236(7):4888-4901. PubMed ID: 33372284
[TBL] [Abstract][Full Text] [Related]
14. EPO-R+ myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells.
Miura S; Kobune M; Horiguchi H; Kikuchi S; Iyama S; Murase K; Goto A; Ikeda H; Takada K; Miyanishi K; Kato J
Blood Cells Mol Dis; 2019 Sep; 78():1-8. PubMed ID: 31082798
[TBL] [Abstract][Full Text] [Related]
15. Hepcidin-25/erythroferrone ratio predicts improvement of anaemia in haemodialysis patients treated with ferric citrate hydrate.
Hara M; Nakamura Y; Suzuki H; Asao R; Nakamura M; Nishida K; Kenmotsu S; Inagaki M; Tsuji M; Kiuchi Y; Ohsawa I; Goto Y; Gotoh H
Nephrology (Carlton); 2019 Aug; 24(8):819-826. PubMed ID: 30239062
[TBL] [Abstract][Full Text] [Related]
16. Induction of erythroferrone in healthy humans by micro-dose recombinant erythropoietin or high-altitude exposure.
Robach P; Gammella E; Recalcati S; Girelli D; Castagna A; Roustit M; Lundby C; Lundby AK; Bouzat P; Vergès S; Séchaud G; Banco P; Uhr M; Cornu C; Sallet P; Cairo G
Haematologica; 2021 Feb; 106(2):384-390. PubMed ID: 31919080
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin as a potential biomarker for blood doping.
Leuenberger N; Bulla E; Salamin O; Nicoli R; Robinson N; Baume N; Saugy M
Drug Test Anal; 2017 Jul; 9(7):1093-1097. PubMed ID: 27758046
[TBL] [Abstract][Full Text] [Related]
18. Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.
Nai A; Rubio A; Campanella A; Gourbeyre O; Artuso I; Bordini J; Gineste A; Latour C; Besson-Fournier C; Lin HY; Coppin H; Roth MP; Camaschella C; Silvestri L; Meynard D
Blood; 2016 May; 127(19):2327-36. PubMed ID: 26755707
[TBL] [Abstract][Full Text] [Related]
19. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y
Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488
[TBL] [Abstract][Full Text] [Related]
20. Serum erythroferrone levels during the first month of life in premature infants.
Lenhartová N; Ochiai M; Sawano T; Yasuoka K; Fujiyoshi J; Inoue H; Ohga S
J Perinatol; 2022 Jan; 42(1):97-102. PubMed ID: 34376791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
